Share on

Asia Pacific Blood Testing Market – Segmented By Cancer Type, Diseases, Methods & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) – Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 1332
Pages: 145
Formats: report pdf report excel report power bi report ppt

Asia Pacific Blood Testing Market Size (2022 to 2027)

According to the report, the size of Asia Pacific Blood Testing Market size is valued at USD 10.34 billion in 2022. This value is forecasted to be growing at a CAGR of 3.35% to reach USD 12.19 billion by 2027.

The blood testing market involves blood sampling and collection activities. Blood testing helps doctors to identify, detect any underlying issues in the body through blood tests. HIV/AIDS, Diabetes, Cancers, and any other Heart issues can be detected through blood tests.

Key factors contributing to the growth of this market contain the growing number of chronic cases and the high price of treatment, rise in occurrence of infectious diseases, speedily increasing aging population, boost in product approvals and launches, increase in demand for quick diagnostic techniques, and high commonness of bloodstream infections.

The Asia Pacific has reported as fastest growing market for Blood testing. The dense population in this region drives the market growth. The demand for frequent check-ups for increasing diseases such as Diabetes, Cancers, Liver Diseases, and Cardiovascular disorders increases market size. The government schemes in this region on creating awareness of medications, blood donation drives, and personalizing medications depending on body type are a boom to market.

During the forthcoming years, Asia-Pacific has been recognized as the fastest-growing region. Blood is a vital component of the body and is used routinely in a wide range of hospital procedures. Every year, millions of blood units are donated globally and used in necessary transplantation, cancer therapies, and accident victims and for patients undergoing other forms of surgeries.

Still, factor such as lack of technically skilled professionals is restraining the growth of this market.

This research report on the Asia Pacific Blood Testing Market has been segmented and sub-segmented into the following categories:

By Type:

  • Complete Blood Count
    • Red Blood Cells
    • White Blood Cells
    • Hemoglobin
    • Haematocrit
    • Platelets
  • Blood Chemistry Tests
    • Electrolytes
    • Blood Glucose
    • Calcium
    • Test for Kidney Function
  • Blood Enzymes Tests
    • Troponin
    • Creatine Kinase
  • Blood Clotting Tests
    • Prothrombin time
    • Activated Partial Thromboplastin time
    • Blood Coagulation

By Disease:

  • Anemia
  • Infection
  • Leukemia
  • Hypokalemia
  • Kidney Disorders
  • Heart Attack
  • Coronary Heart Disease

By Method:

  • Manual Blood Culture Testing
  • Automated Blood Culture Testing
  • Automated Blood Culture System
  • Blood Culture Instruments

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Based on the region, China and India are the fastest-growing markets in the Asia-Pacific region. China and Japan are highly populated regions, and hence the spread of infectious diseases is on the rise every year, notably. The regulations and strict guidelines are made by the corresponding government to regulate and prevent infections. 47% of the Asia Pacific population is reported to donate blood in recent years. As the hike is seen in blood donation and drives, blood collection and sampling are also observed. India holds the largest share for blood banks, helping hospitals and clinics provide blood in emergency cases. Growing major vital players across the Asia Pacific region also leads the market level to rise.

Companies dominating the Asia Pacific Blood Testing Market Profiled in the Report are Bio-Rad Laboratories Inc. (U.S.), Siemens Healthcare (Germany), Grifols (Spain), Nanosphere Inc. (U.S.), BioMérieux (France), Dickinson and Company (U.S.), Ortho Clinical Diagnostics Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.) and Beckman Coulter (U.S.).

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample